|
|
|
Volumn 144, Issue 23, 2000, Pages 32-35
|
|
ACR focuses on new and emerging arthritis drugs
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CYCLOPHOSPHAMIDE;
ETANERCEPT;
INFLIXIMAB;
INTERLEUKIN 1;
LEFLUNOMIDE;
METHOTREXATE;
PREDNISOLONE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RITUXIMAB;
ARTHRITIS;
B LYMPHOCYTE;
CLINICAL TRIAL;
DIAGNOSTIC IMAGING;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG LABELING;
DRUG RESEARCH;
DRUG TARGETING;
HUMAN;
JOINT DESTRUCTION;
LONG TERM CARE;
QUALITY OF LIFE;
SHORT SURVEY;
TREATMENT OUTCOME;
|
|
EID: 0034638857
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|